Lessons learned from an HR-pQCT study in adults with osteogenesis imperfecta (#230)
BETTINA M Willie
1
,
Seyedmahdi Hosseinitabatabaei
1
,
Nicholas Mikolajewicz
1
,
Catherine Julien
1
,
Elizabeth A Zimmermann
1
- McGill University/Shriners Hospital for Children-Canada, Montreal, QC, Canada
Publish consent withheld
- References: 1) Mikolajewicz et al. J Bone Miner Res. 2020;35(3):446-59, 2) Samelson et al. Lancet Diabetes Endocrinol. 2019;7(1):34-43, 3) Mikolajewicz et al. Bone 147 (2021) 115880. 4) Glorieux et al. J Bone Miner Res. in revision, 5) Folkestad et al. J Bone Miner Res. 2012;27(6):1405-12, 6) Flehr et al. Osteoporos Int. 2022;33(7):1545-56.
Acknowledgements: Mereo BioPharma, Ultragenyx, and Shriners Hospitals for Children